Company Profile
BioStem Technologies Stock Price, News & Analysis
- Ticker:
- BSEM
- Exchange:
- 美国金融业监管局 (FINRA) 场外柜台交易系统
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on 美国金融业监管局 (FINRA) 场外柜台交易系统, BioStem Technologies is followed within the biotech universe for its exposure to catalyst-driven execution.
Stock performance
3.70 USD (-4.93%)
Close
Last updated: June 23, 2026 at 00:00
—
Market cap
Why the stock is moving
BSEM is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
BioStem Technologies is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
Geographic Base and Sector Classification
Headquartered in the United States and listed on 美国金融业监管局 (FINRA) 场外柜台交易系统, BioStem Technologies is followed within the biotech universe for its exposure to catalyst-driven execution.
Business Model Characteristics
BioStem Technologies follows a catalyst-driven model where the market watches how the company turns development work into repeatable value creation.
Position Within the Biotechnology Landscape
Compared with more mature healthcare peers, BioStem Technologies sits closer to the development side of the biotechnology landscape, where timing around data and approvals matters most.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of BioStem Technologies (BSEM)?
BioStem Technologies (BSEM) most recently closed at 3.70 USD, a -4.93% move versus the previous session.
What does BioStem Technologies do?
BioStem Technologies is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
On which exchange is BSEM stock listed?
BioStem Technologies (BSEM) is associated with 美国金融业监管局 (FINRA) 场外柜台交易系统, Headquartered in the United States and listed on 美国金融业监管局 (FINRA) 场外柜台交易系统, BioStem Technologies is followed within the biotech universe for its exposure to catalyst-driven execution., Biotechnology.
What is BioStem?
BioStem Technologies is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.
Which conditions is BioStem Technologies targeting with BioStem?
BioStem Technologies is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
What is Technologies?
BioStem Technologies is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.
What is Investors?
Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.